• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】16223

【品名】(8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione

【CA登记号】21794-55-8

【 分 子 式 】C21H18O8

【 分 子 量 】398.36912

【元素组成】C 63.32% H 4.55% O 32.13%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(VII)

The sulfonation of methyl N-trifluoroacetyldaunosaminide (I) with mesyl chloride or with 4-bromophenylsulfonyl chloride in pyridine gives the corresponding 4-O-mesyl derivative (II) or 4-O-(4-bromophenylsulfonyl) derivative (IIa); both compounds by reaction with NaI in refluxing butanone yield the 4-iodo compound (III). The hydrogenation of (III) with H2 over Pd/C in methanol, followed by hydrolysis with hot acetic acid yields 4-deoxy-N-trifluoroacetyldaunosaminide (IV), which is esterified with p-nitrobenzoyl chloride in pyridine affording the corresponding p-nitrobenzoyl ester (V). The reaction of (V) with dry HCl in methylene chloride gives 1,4-dideoxy-N-trifluoroacetyldanosaminide (VI), which is condensed with daunomycinone (VII) by means of silver trifluoromethylsulfonate in methylene chloride and hydrolyzed with NaOH to afford 4'-deoxy-daunomycine (VIII). The bromination of (VIII) with Br2 in methanol-dioxane gives 4'-deoxy-14-bromodaunomycine (IX), which is finally hydrolyzed with aqueous sodium formate.

1 Penco, S.; Arcamone, F.; Di Marco, A.; Novel antitumor glycosides of the anthracycline series and process for their preparation. FR 2325659 .
2 Arcamone, F.; Penco, S.; Redaelli, S.; Hanessian, S.; Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin. J Med Chem 1976, 19, 1424-25.
3 Robinson, C.P.; Prous, J.; Castaner, J.; ESORUBICIN HYDROCHLORIDE < Rec INNM; USAN >. Drugs Fut 1990, 15, 10, 986.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 18941 p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride 122-04-3 C7H4ClNO3 详情 详情
(A) 18964 4-bromobenzenesulfonyl chloride 98-58-8 C6H4BrClO2S 详情 详情
(IIa) 31180 (2S,3S,4S,6R)-6-methoxy-2-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydro-2H-pyran-3-yl 4-bromobenzenesulfonate C15H17BrF3NO6S 详情 详情
(I) 30693 2,2,2-trifluoro-N-[(2S,3S,4S,6R)-3-hydroxy-6-methoxy-2-methyltetrahydro-2H-pyran-4-yl]acetamide C9H14F3NO4 详情 详情
(II) 31179 (2S,3S,4S,6R)-6-methoxy-2-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydro-2H-pyran-3-yl methanesulfonate C10H16F3NO6S 详情 详情
(III) 31181 2,2,2-trifluoro-N-[(2S,3R,4S,6R)-3-iodo-6-methoxy-2-methyltetrahydro-2H-pyran-4-yl]acetamide C9H13F3INO3 详情 详情
(IV) 31182 2,2,2-trifluoro-N-[(2R,4R,6S)-2-hydroxy-6-methyltetrahydro-2H-pyran-4-yl]acetamide C8H12F3NO3 详情 详情
(V) 31183 (2S,4R,6S)-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydro-2H-pyran-2-yl 4-nitrobenzoate C15H15F3N2O6 详情 详情
(VI) 31184 N-[(2S,4R,6S)-2-chloro-6-methyltetrahydro-2H-pyran-4-yl]-2,2,2-trifluoroacetamide C8H11ClF3NO2 详情 详情
(VII) 16223 (8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 21794-55-8 C21H18O8 详情 详情
(VIII) 31185 (8S,10S)-8-acetyl-10-[[(2S,4R,6S)-4-amino-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C27H29NO9 详情 详情
(IX) 31186 (8S,10S)-10-[[(2S,4R,6S)-4-amino-6-methyltetrahydro-2H-pyran-2-yl]oxy]-8-(2-bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C27H28BrNO9 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IX)

L-Fucose (I) is converted successively to its methyl glucoside (II), the 3,4-O-isopropylidene derivative (III), the 2-O-acetyl derivative (IV), the 2-O-acetyl-L-methylfucoside (V), the tosylate (VI), the 4-O-benzyl derivative (VII) and finally, through various steps, the 3,4-O-diacetyl-2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl bromide (VIII). The condensation of (VIII) with daunomycinone (IX) gives the daunomycin derivative (X), which is converted to the isopropylidene derivative (XI). The bromination of (XI) affords the bromo derivative (XII).

1 Hoshi, A.; Prous, J.; Castaner, J.; ME2303. Drugs Fut 1989, 14, 8, 756.
2 Omoto, S.; Kondo, S.; Fukatsu, S.; Takeuchi, T.; Umezawa, K.; Tsuchiya, T.; Umezawa, S.; Biological properties of ME2303 (FAD-104), a new anthracycline. Drug Exp Clin Res 1988, 14, 7, 435-9.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21215 6-methyltetrahydro-2H-pyran-2,3,4,5-tetrol C6H12O5 详情 详情
(II) 21216 2-methoxy-6-methyltetrahydro-2H-pyran-3,4,5-triol 14917-55-6 C7H14O5 详情 详情
(III) 21217 8-methoxy-3,3,6-trimethylhexahydro-2H,6H-pyrano[3,4-b][1,4]dioxepin-9-ol C12H22O5 详情 详情
(IV) 21218 8-methoxy-3,3,6-trimethylhexahydro-2H,6H-pyrano[3,4-b][1,4]dioxepin-9-yl acetate C14H24O6 详情 详情
(V) 21219 4,5-dihydroxy-2-methoxy-6-methyltetrahydro-2H-pyran-3-yl acetate C9H16O6 详情 详情
(VI) 21220 5-hydroxy-2-methoxy-6-methyl-4-[[(4-methylphenyl)sulfonyl]oxy]tetrahydro-2H-pyran-3-yl acetate C16H22O8S 详情 详情
(VII) 21221 5-(acetoxy)-6-methoxy-2-methyl-4-[[(4-methylphenyl)sulfonyl]oxy]tetrahydro-2H-pyran-3-yl 2-phenylacetate C24H28O9S 详情 详情
(VIII) 21222 3-(acetoxy)-6-bromo-5-fluoro-2-methyltetrahydro-2H-pyran-4-yl acetate C10H14BrFO5 详情 详情
(IX) 16223 (8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 21794-55-8 C21H18O8 详情 详情
(X) 21224 3-(acetoxy)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-5-fluoro-2-methyltetrahydro-2H-pyran-4-yl acetate C31H31FO13 详情 详情
(XI) 21225 (8S,10S)-8-acetyl-10-[(9-fluoro-3,3,6-trimethylhexahydro-2H,6H-pyrano[3,4-b][1,4]dioxepin-8-yl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C32H35FO11 详情 详情
(XII) 21226 (8R,10S)-8-(2-bromoacetyl)-10-[(9-fluoro-3,3,6-trimethylhexahydro-2H,6H-pyrano[3,4-b][1,4]dioxepin-8-yl)oxy]-6,11-dihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C32H34BrFO10 详情 详情

合成路线3

该中间体在本合成路线中的序号:(III)

Coupling of daunomycinone (III) with 3,4-di-O-acetyl-2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl bromide (II), which was obtained from 1,3,4-tri-O-acetyl-derivative (I), was performed by a Koenings-Knorr type of reaction to obtain the daunomycin derivative (IV). Deprotection of (IV) with sodium hydroxide in water gave corresponding derivative (V), which was subsequently treated with bromine in dichloromethane and acetone to afford the bromo derivative (VI). Condensation of (VI) with N-Boc-beta-alanine sodium salt (VII) in acetone/water gave the protected beta-alaninate derivative (VIII), which was finally treated with hydrochloride in ether to obtain DA-125.

1 Ok, D.K.; Kim, M.S.; Jung, D.Y. (Dong-A Pharmaceutical Co., Ltd.); L-Talopyranoside derivs. and process for the preparation of same. US 5374746 .
2 Lee, M.G.; Yang, J.; DA-125. Drugs Fut 1996, 21, 8, 782.
3 Tsuchiya, T.; Takagi, Y.; Oka, K.D.; Umezawa, S.; Takeuchi, T.; Wako, N.; Umezawa, H.; Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and adriamycinone. J Antibiot 1986, 39, 11, 731-3.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16221 (2S,3R,4R,5R,6S)-2,5-bis(acetoxy)-3-fluoro-6-methyltetrahydro-2H-pyran-4-yl acetate C12H17FO7 详情 详情
(II) 16222 (2S,3S,4R,5R,6S)-3-(acetoxy)-6-bromo-5-fluoro-2-methyltetrahydro-2H-pyran-4-yl acetate C10H14BrFO5 详情 详情
(III) 16223 (8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 21794-55-8 C21H18O8 详情 详情
(IV) 16224 (2S,3R,4R,5R,6R)-3-(acetoxy)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-5-fluoro-2-methyltetrahydro-2H-pyran-4-yl acetate C31H31FO13 详情 详情
(V) 16225 (8S,10S)-8-acetyl-10-[[(2R,3R,4R,5S,6S)-3-fluoro-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C27H27FO11 详情 详情
(VI) 16226 (8S,10S)-10-[[(3aR,4S,6R,7R,7aR)-7-fluoro-2,2,4-trimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-6-yl]oxy]-8-(2-bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C30H30BrFO11 详情 详情
(VII) 16227 sodium 3-[(tert-butoxycarbonyl)amino]propanoate C8H14NNaO4 详情 详情
(VIII) 16228 2-((2S,4S)-4-[[(3aR,4S,6R,7R,7aR)-7-fluoro-2,2,4-trimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-6-yl]oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-naphthacenyl)-2-oxoethyl 3-[(tert-butoxycarbonyl)amino]propanoate C38H44FNO15 详情 详情
(IX) 16229 2-((2S,4S)-4-[[(2R,3R,4R,5S,6S)-3-fluoro-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-naphthacenyl)-2-oxoethyl 3-aminopropanoate C30H32FNO13 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Condensation of daunomycinone (I) with aminoglycal (II) in the presence of triphenylphosphine hydrobromide provided the protected hexopyranosyl daunomycinone (III). Deacetylation with K2CO3 in MeOH-CH2Cl2 gave alcohol (IV), and further hydrolysis of the trifluoroacetamide with NaOH yielded amine (V), which was isolated as the hydrochloride. Finally, condensation of two molecules of (V) with a,a'-dibromo-p-xylene (VI) in the presence of Na2CO3 in DMF-CH2Cl2 at room temperature, followed by precipitation of the dihydrochloride from MeOH-Et2O, provided the target compound.

1 Priebe, W.; Chaires, J.B.; Przewloka, T.; Fokt, I.; Perez-Soler, R.; Bis-anthracyclines with high activity against doxorubicin resistant tumors. EP 0971716; JP 2000506899; WO 9734612 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16223 (8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 21794-55-8 C21H18O8 详情 详情
(II) 18693 (2S,3R,4S)-2-methyl-3-[(2,2,2-trifluoroacetyl)amino]-3,4-dihydro-2H-pyran-4-yl acetate C10H12F3NO4 详情 详情
(III) 18694 (2S,3R,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-2-methyl-3-[(2,2,2-trifluoroacetyl)amino]tetrahydro-2H-pyran-4-yl acetate C31H30F3NO12 详情 详情
(IV) 18695 N-((2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)-2,2,2-trifluoroacetamide C29H28F3NO11 详情 详情
(V) 18696 (8S,10S)-8-acetyl-10-[[(2R,4S,5S,6S)-5-amino-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C27H29NO10 详情 详情
(VI) 18697 1,4-bis(bromomethyl)benzene 623-24-5 C8H8Br2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VI)

Reduction of ketone (I) with NaBH4 in MeOH at low temperature yielded alcohol (II) as the major product. This was treated with trifluoromethanesulfonic anhydride to provide triflate (III), which was displaced with NaI to form iodide (IV). Acetolysis of the methyl pyranoside (IV) produced the 1-alpha-O-acetyl derivative (V) along with minor amounts of the beta-anomer. The reaction of (V) with dry HCl in benzene gave the corresponding glycosyl chloride, which was subsequently coupled with daunorubicinone (VI) using HgO and HgBr2 to provide the title compound as the major anomer.

1 Pierre, A.; Aligiannis, N.; Skaltsounis, A.-L.; Marakos, P.; Leonce, S.; Atassi, G.; Pouli, N.; Mitaku, S.; Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo-hexopyranosyl)daunomycinone. Chem Pharm Bull 2000, 48, 1, 150.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46981 (2S,3S,6R)-6-methoxy-2-methyl-4-oxotetrahydro-2H-pyran-3-yl acetate C9H14O5 详情 详情
(II) 46982 (2S,3R,4R,6R)-4-hydroxy-6-methoxy-2-methyltetrahydro-2H-pyran-3-yl acetate C9H16O5 详情 详情
(III) 46983 (2S,3S,4R,6R)-6-methoxy-2-methyl-4-[[(trifluoromethyl)sulfonyl]oxy]tetrahydro-2H-pyran-3-yl acetate C10H15F3O7S 详情 详情
(IV) 46984 (2S,3S,4S,6R)-4-iodo-6-methoxy-2-methyltetrahydro-2H-pyran-3-yl acetate C9H15IO4 详情 详情
(V) 46985 (2S,3S,4S,6S)-6-(acetoxy)-4-iodo-2-methyltetrahydro-2H-pyran-3-yl acetate C10H15IO5 详情 详情
(VI) 16223 (8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 21794-55-8 C21H18O8 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

 

1 Van Der Rijst M, Scheeren JW, et aL.1998. A process for preparing epirubicin or acid addition salts thereof from daunorubicin. EP 848009
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66341 (8S,10S)-8-acetyl-10-((4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride   C27H29NO10.HCl 详情 详情
(II) 16223 (8S,10S)-8-acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 21794-55-8 C21H18O8 详情 详情
(III) 66342 4-amino-6-methoxy-2-methyltetrahydro-2H-pyran-3-ol hydrochloride   C7H15NO3.HCl 详情 详情
(IV) 66346 2-oxo-2-(2,4,5,12-tetrahydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl acetate   C23H20O10 详情 详情
(V) 30693 2,2,2-trifluoro-N-[(2S,3S,4S,6R)-3-hydroxy-6-methoxy-2-methyltetrahydro-2H-pyran-4-yl]acetamide C9H14F3NO4 详情 详情
(VI) 30694 2,2,2-trifluoro-N-[(2S,4S,6R)-6-methoxy-2-methyl-3-oxotetrahydro-2H-pyran-4-yl]acetamide C9H12F3NO4 详情 详情
(VII) 30695 2,2,2-trifluoro-N-[(2S,3R,4S,6R)-3-hydroxy-6-methoxy-2-methyltetrahydro-2H-pyran-4-yl]acetamide C9H14F3NO4 详情 详情
(VIII) 30696 N-[(2S,3R,4S,6R)-3,6-dihydroxy-2-methyltetrahydro-2H-pyran-4-yl]-2,2,2-trifluoroacetamide C8H12F3NO4 详情 详情
(IX) 66343 5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2-yl 2,2,2-trifluoroacetate   C10H11F6NO5 详情 详情
(X) 66344 2-oxo-2-(2,5,12-trihydroxy-4-((5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl acetate   C31H30F3NO13 详情 详情
(XI) 66345 2,2,2-trifluoro-N-(3-hydroxy-2-methyl-6-((3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide   C29H28F3NO12 详情 详情
(XII) 30701 2,2,2-trifluoro-N-[(2S,3R,4S,6R)-3-hydroxy-2-methyl-6-([(1S,3S)-3,5,12-trihydroxy-10-methoxy-3-[(4R)-4-methoxy-2,2-dimethyl-1,3-dioxolan-4-yl]-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy)tetrahydro-2H-pyran-4-yl]acetamide C33H36F3NO13 详情 详情
Extended Information